Kapur Navin K, Pahuja Mohit, Kochar Ajar, Karas Richard H, Udelson James E, Moses Jeffrey W, Stone Gregg W, Aghili Nima, Faraz Haroon, O'Neill William W
Tuft University Medical Center, Boston, MA, United States of America.
University of Oklahoma Medical Science, Oklahoma city, OK, United States of America.
Cardiovasc Revasc Med. 2024 Mar;60:11-17. doi: 10.1016/j.carrev.2023.09.009. Epub 2023 Oct 9.
The STEMI-DTU pilot study tested the early safety and practical feasibility of left ventricular (LV) unloading with a trans-valvular pump before reperfusion. In the intent-to-treat cohort, no difference was observed for microvascular obstruction (MVO) or infarct size (IS) normalized to either the area at risk (AAR) at 3-5 days or total LV mass (TLVM) at 3-5 days We now report a per protocol analysis of the STEMI-DTU pilot study.
In STEMI-DTU STUDY 50 adult patients (25 in each arm) with anterior STEMI [sum of precordial ST-segment elevation (ΣSTE) ≥4 mm] requiring primary percutaneous coronary intervention (PCI) were enrolled. Only patients who met all inclusion and exclusion criteria were included in this analysis. Cardiac magnetic resonance (CMR) imaging 3-5 days after PCI quantified IS/AAR and IS/TLVM and MVO. Group differences were assessed using Student's t-tests and linear regression (SAS Version-9.4).
Of the 50 patients enrolled, 2 died before CMR imaging. Of the remaining 48 patients those without CMR at 3-5 days (n = 8), without PCI of a culprit left anterior descending artery lesion (n = 2), with OHCA (n = 1) and with ΣSTE < 4 mm (n = 5) were removed from this analysis leaving 32/50 (64 %) patients meeting all inclusion and exclusion criteria (U-IR, n = 15; U-DR, n = 17) as per protocol. Despite longer symptom-to-balloon times in the U-DR arm (228 ± 80 vs 174 ± 59 min, p < 0.01), IS/AAR was significantly lower with 30 min of delay to reperfusion in the presence of active LV unloading (47 ± 16 % vs 60 ± 15 %, p = 0.02) and remained lower irrespective of the magnitude of precordial ΣSTE. MVO was not significantly different between groups (1.5 ± 2.8 % vs 3.5 ± 4.8 %, p = 0.15). Among patients who received LV unloading within 180 min of symptom onset, IS/AAR was significantly lower in the U-DR group.
In this per-protocol analysis of the STEMI-DTU pilot study we observed that LV unloading for 30 min before reperfusion significantly reduced IS/AAR compared to LV unloading and immediate reperfusion, whereas in the ITT cohort no difference was observed between groups. This observation supports the design of the STEMI-DTU pivotal trial and suggests that strict adherence to the study protocol can significantly influence the outcome.
STEMI-DTU试点研究测试了在再灌注前使用经瓣膜泵进行左心室(LV)卸载的早期安全性和实际可行性。在意向性治疗队列中,在3 - 5天时,以危险区域(AAR)或3 - 5天的左心室总质量(TLVM)标准化后的微血管阻塞(MVO)或梗死面积(IS)未观察到差异。我们现在报告STEMI-DTU试点研究的符合方案分析。
在STEMI-DTU研究中,纳入了50例患有前壁ST段抬高型心肌梗死(STEMI)[胸前导联ST段抬高总和(ΣSTE)≥4 mm]需要进行直接经皮冠状动脉介入治疗(PCI)的成年患者(每组25例)。只有符合所有纳入和排除标准的患者才纳入本分析。PCI术后3 - 5天进行心脏磁共振(CMR)成像,量化IS/AAR、IS/TLVM和MVO。使用学生t检验和线性回归(SAS版本9.4)评估组间差异。
在纳入的50例患者中,2例在CMR成像前死亡。在其余48例患者中,将3 - 5天时未进行CMR检查的患者(n = 8)、罪犯左前降支病变未进行PCI的患者(n = 2)、发生院外心脏骤停(OHCA)的患者(n = 1)以及ΣSTE < 4 mm的患者(n = 5)排除在本分析之外,按照方案有32/50(64%)的患者符合所有纳入和排除标准(U-IR组,n = 15;U-DR组,n = 17)。尽管U-DR组症状出现至球囊扩张时间更长(228 ± 80 vs 174 ± 59分钟,p < 0.01),但在存在主动LV卸载的情况下,再灌注延迟30分钟时IS/AAR显著降低(47 ± 16% vs 60 ± 15%,p = 0.02),并且无论胸前导联ΣSTE的大小如何均保持较低水平。两组间MVO无显著差异(1.5 ± 2.8% vs 3.5 ± 4.8%,p = 0.15)。在症状发作180分钟内接受LV卸载的患者中,U-DR组的IS/AAR显著更低。
在STEMI-DTU试点研究的这项符合方案分析中,我们观察到与LV卸载后立即再灌注相比,再灌注前LV卸载30分钟显著降低了IS/AAR,而在意向性治疗队列中组间未观察到差异。这一观察结果支持了STEMI-DTU关键试验的设计,并表明严格遵守研究方案可显著影响结果。